HAEMGENIX

Live / Registered — Registered (as of 02 Mar 2021)

What this means for you

Registered since 02 Mar 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 02 Mar 2027, and its filing window is open now).

Record

Serial number
88947760
Registration number
6280671
Mark type
Word mark
Filed
04 Jun 2020
Published for opposition
15 Dec 2020
Registered
02 Mar 2021
Next maintenance filing
§8 declaration of use, due by 02 Mar 2027 (grace period to 02 Sept 2027)
Attorney of record
Scott D. Woldow

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of hemophilia; clinical medical reagents for use in gene therapy, gene diagnosis and gene testing

Owner

Prosecution history

  • 02 Mar 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 12 Aug 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 12 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 12 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 12 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 12 Aug 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 20 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 20 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 20 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 08 Jun 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 02 Mar 2021 — REGISTERED-PRINCIPAL REGISTER
  • 15 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 15 Dec 2020 — PUBLISHED FOR OPPOSITION
  • 25 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 12 Nov 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER

View this trademark record on Rightsy